<?xml
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel xml:lang="fr">
	<title>Joseph Larmarange</title>
	<link>https://joseph.larmarange.net/</link>
	<description>D&#233;mographe en sant&#233; publique, directeur de recherche HDR &#224; l'IRD,directeur adjoint du Ceped (UMR 196 Universit&#233; Paris Cit&#233;, IRD, Universit&#233; Sorbonne Paris Nord, Inserm)</description>
	<language>fr</language>
	<generator>SPIP - www.spip.net</generator>
	<atom:link href="https://joseph.larmarange.net/spip.php?id_mot=128&amp;page=backend" rel="self" type="application/rss+xml" />

	<image>
		<title>Joseph Larmarange</title>
		<url>https://joseph.larmarange.net/local/cache-vignettes/L144xH52/joseph_larmarange_site-6e82f.svg?1649686173</url>
		<link>https://joseph.larmarange.net/</link>
		<height>52</height>
		<width>144</width>
	</image>



<item xml:lang="en">
		<title>Incidence of HIV infection and associated factors among female sex workers in C&#244;te d'Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays</title>
		<link>https://joseph.larmarange.net/incidence-of-hiv-infection-and</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/incidence-of-hiv-infection-and</guid>
		<dc:date>2022-11-19T09:08:52Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>
		<dc:subject>Pr&#233;carit&#233;</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Marcellin N. Nouaman, Valentine Becquet, M&#233;lanie Plazy, Patrick A. Coffie, Cl&#233;mence Z&#233;bago, Alice Montoyo, Camille Anoma, Serge Eholi&#233;, Fran&#231;ois Dabis, Joseph Larmarange, for the ANRS 12361 PrEP-CI Study group &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background This study aimed to estimate, using an HIV Recent Infection Testing Algorithm (RITA), the HIV incidence and its associated factors among female sex workers (FSW) in C&#244;te d'Ivoire. &lt;br class='autobr' /&gt;
Methods A cross-sectional study was conducted in 2016&#8211;2017 in Abidjan&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Precarite-+" rel="tag"&gt;Pr&#233;carit&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH112/2016-12-09_12.12_22-8b072.jpg?1763092898' class='spip_logo spip_logo_right' width='150' height='112' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3860637&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-03860637v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L58xH75/thumb-7ad5f6fe-e734b.png?1702969505' alt=&#034;Image document&#034; width='58' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-03860637v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Incidence of HIV infection and associated factors among female sex workers in C&#244;te d'Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+N.+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin N. Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Patrick+A.+Coffie&#034; class=&#034;hal-auteur&#034;&gt;Patrick A. Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cl%C3%A9mence+Z%C3%A9bago&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Z&#233;bago&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Alice+Montoyo&#034; class=&#034;hal-auteur&#034;&gt;Alice Montoyo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Camille+Anoma&#034; class=&#034;hal-auteur&#034;&gt;Camille Anoma&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Serge+Eholi%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196998&#034; class=&#034;hal-auteur&#034;&gt;Fran&#231;ois Dabis&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;PLoS ONE&lt;/i&gt;, 2022, 17 (11), pp.e0271988. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1371/journal.pone.0271988&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1371/journal.pone.0271988&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-03860637v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-03860637&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Marcellin N. Nouaman, Valentine Becquet, M&#233;lanie Plazy, Patrick A. Coffie, Cl&#233;mence Z&#233;bago, Alice Montoyo, Camille Anoma, Serge Eholi&#233;, Fran&#231;ois Dabis, Joseph Larmarange, for the ANRS 12361 PrEP-CI Study group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt; This study aimed to estimate, using an HIV Recent Infection Testing Algorithm (RITA), the HIV incidence and its associated factors among female sex workers (FSW) in C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt; A cross-sectional study was conducted in 2016&#8211;2017 in Abidjan and San Pedro's region among FSW aged &#8805; 18 years. In addition, a sociodemographic questionnaire, HIV screening was carried out by two rapid tests. In the event of a positive result, a dried blood spot sample was taken to determine, using a RITA adapted to the Ivorian context, if it was a recent HIV infection.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt; A total of 1000 FSW were surveyed with a median age of 25 years (interquartile range: 21&#8211;29 years). 39 (3.9%) tested positive for HIV. The incidence of HIV was estimated to be 2.3 per 100 person-years, with higher incidence rates among those 24 years old or less (3.0% vs. 1.9%), non-Ivorian FSW (3.2% vs. 1.9%) and those with the lowest education level (4.6% in FSW who never went to school vs. 2.6%). The incidence seemed to be associated with the sex work practice conditions: higher incidence among FSW whose usual price was less than 3.50$ (4.3% vs.1.0%), FSW who had a larger number of clients on the last day of work (6.1% in those with 7 clients or more vs. 1.8%), FSW who reported not always using condoms with their clients (8.5% vs. 1.5%) and FSW who reported agreeing to sex without a condom in exchange for a large sum of money (10.1% vs. 1.2%).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt; This study confirms that FSW remain highly exposed to HIV infection. Exposure to HIV is also clearly associated with certain sex-work factors and the material conditions of sex work. Efforts in the fight against HIV infection must be intensified to reduce new infections among FSW.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne</title>
		<link>https://joseph.larmarange.net/hdr</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/hdr</guid>
		<dc:date>2022-10-14T06:38:12Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>CAP-CoV-Soignants-BF</dc:subject>
		<dc:subject>DOD-CI (ANRS 12287 / 12323)</dc:subject>
		<dc:subject>ELIHoS (ANRS 12139)</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Pr&#233;valences du VIH (ANRS 12114)</dc:subject>
		<dc:subject>prevR</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Burkina Faso</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Analyse de s&#233;quences</dc:subject>
		<dc:subject>Approches biographiques</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>Cartographie</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Comparaison de cohortes</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>D&#233;mographie</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)</dc:subject>
		<dc:subject>Enqu&#234;tes par t&#233;l&#233;phone</dc:subject>
		<dc:subject>Enseignement acad&#233;mique</dc:subject>
		<dc:subject>Lien vers les soins</dc:subject>
		<dc:subject>&#201;pid&#233;miologie</dc:subject>
		<dc:subject>Essais cliniques</dc:subject>
		<dc:subject>Estimateurs &#224; noyau (kernel density estimation)</dc:subject>
		<dc:subject>Femmes enceintes</dc:subject>
		<dc:subject>Financement des programmes</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>
		<dc:subject>Interpolation spatiale</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Masculinit&#233;s</dc:subject>
		<dc:subject>M&#233;nages</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Observatoire de population</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;valence du VIH</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;</dc:subject>
		<dc:subject>Repr&#233;sentations / Perceptions</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Structure des populations</dc:subject>
		<dc:subject>Structures de sant&#233;</dc:subject>
		<dc:subject>Surveillance sentinelle</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>
		<dc:subject>Temporalit&#233;s</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>
		<dc:subject>Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;. &lt;br class='autobr' /&gt; D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne &lt;br class='autobr' /&gt; Joseph Larmarange D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022 HDR tel-03814024&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-CAP-CoV-Soignants-BF-+" rel="tag"&gt;CAP-CoV-Soignants-BF&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-DOD-CI-ANRS-12287-+" rel="tag"&gt;DOD-CI (ANRS 12287 / 12323)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-ELIHoS-ANRS-12139-+" rel="tag"&gt;ELIHoS (ANRS 12139)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevalences-du-VIH-ANRS-12114-+" rel="tag"&gt;Pr&#233;valences du VIH (ANRS 12114)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-prevR-+" rel="tag"&gt;prevR&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Burkina-Faso-+" rel="tag"&gt;Burkina Faso&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Analyse-de-sequences-+" rel="tag"&gt;Analyse de s&#233;quences&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Approches-biographiques-+" rel="tag"&gt;Approches biographiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cartographie-+" rel="tag"&gt;Cartographie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Comparaison-de-cohortes-+" rel="tag"&gt;Comparaison de cohortes&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Demographie-+" rel="tag"&gt;D&#233;mographie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-EDS-Enquetes-Demographiques-et-de-+" rel="tag"&gt;EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Enquetes-par-telephone-+" rel="tag"&gt;Enqu&#234;tes par t&#233;l&#233;phone&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Enseignement-academique-+" rel="tag"&gt;Enseignement acad&#233;mique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Entree-en-soins-+" rel="tag"&gt;Lien vers les soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Epidemiologie-+" rel="tag"&gt;&#201;pid&#233;miologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Essais-cliniques-+" rel="tag"&gt;Essais cliniques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Estimateurs-a-noyau-kernel-density-+" rel="tag"&gt;Estimateurs &#224; noyau (kernel density estimation)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Femmes-enceintes-+" rel="tag"&gt;Femmes enceintes&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Financement-des-programmes-+" rel="tag"&gt;Financement des programmes&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Interpolation-spatiale-+" rel="tag"&gt;Interpolation spatiale&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Masculinites-+" rel="tag"&gt;Masculinit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Menages-+" rel="tag"&gt;M&#233;nages&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Observatoire-de-population-+" rel="tag"&gt;Observatoire de population&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevalence-du-VIH-+" rel="tag"&gt;Pr&#233;valence du VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representations-Perceptions-+" rel="tag"&gt;Repr&#233;sentations / Perceptions&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Structure-des-populations-+" rel="tag"&gt;Structure des populations&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Structures-de-sante-+" rel="tag"&gt;Structures de sant&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Surveillance-sentinelle-+" rel="tag"&gt;Surveillance sentinelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Temporalites-142-+" rel="tag"&gt;Temporalit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Usagers-de-drogue-par-voie-+" rel="tag"&gt;Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH109/ruban_spirales-a3fec.png?1715097926' class='spip_logo spip_logo_right' width='150' height='109' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3814024&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://theses.hal.science/tel-03814024v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-877a2ad2-17cac.png?1702907846' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;D&#233;crire les &#233;pid&#233;mies, Comprendre les populations : une d&#233;mographie du VIH en Afrique subsaharienne&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-hdr&#034;&gt;HDR&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;tel-03814024&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;iframe width=&#034;100%&#034; height=&#034;500&#034; src=&#034;https://www.youtube.com/embed/me6rDSq0p0k&#034; title=&#034;YouTube video player&#034; frameborder=&#034;0&#034; allow=&#034;accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;h2 class=&#034;spip&#034;&gt;
Jury&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Didier Breton (Universit&#233; de Strasbourg, rapporteur)&lt;/li&gt;&lt;li&gt; Val&#233;rie Delauney (IRD, rapportrice)&lt;/li&gt;&lt;li&gt; Annabel Desgr&#233;es du Lo&#251; (IRD, garante)&lt;/li&gt;&lt;li&gt; G&#233;raldine Duth&#233; (Ined, rapportrice)&lt;/li&gt;&lt;li&gt; Didier Ekouevi (Inserm, Universit&#233; de Lom&#233;, examinateur)&lt;/li&gt;&lt;li&gt; V&#233;ronique Petit (Universit&#233; Paris Cit&#233;, pr&#233;sidente)&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://joseph.larmarange.net/IMG/pdf/hdr_larmarange_v2022-10-12.pdf" length="15224200" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>La PrEP seule ne suffit pas&#160;: elle doit &#234;tre accompagn&#233;e d'une offre de soins globale</title>
		<link>https://joseph.larmarange.net/La-PrEP-seule-ne-suffit-pas-elle</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/La-PrEP-seule-ne-suffit-pas-elle</guid>
		<dc:date>2022-05-19T09:49:15Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Contraception</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>

		<description>
&lt;p&gt;Cette note de politique, pr&#233;par&#233;e par PAC-CI, repose sur des r&#233;sultats du projet PrEP-CI ANRS 12361. &lt;br class='autobr' /&gt; La PrEP seule ne suffit pas&#160;: elle doit &#234;tre accompagn&#233;e d'une offre de soins globale &lt;br class='autobr' /&gt; Alexandra Bitty-Anderson , Annick Gui&#233; , Eulalie Kanga , Marcellin Nouaman ,&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Contraception-+" rel="tag"&gt;Contraception&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L100xH150/dsc03314-1d274.jpg?1715146422' class='spip_logo spip_logo_right' width='100' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Cette note de politique, pr&#233;par&#233;e par PAC-CI, repose sur des r&#233;sultats du projet &lt;a href='https://joseph.larmarange.net/Etude-de-faisabilite-en-vue-d-un' class=&#034;spip_in&#034;&gt;PrEP-CI ANRS 12361&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3882265&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://ird.hal.science/ird-03882265v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-bb4eaea8-b9e24.png?1702930409' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-03882265v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;La PrEP seule ne suffit pas : elle doit &#234;tre accompagn&#233;e d'une offre de soins globale&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Alexandra+Bitty-Anderson&#034; class=&#034;hal-auteur&#034;&gt;Alexandra Bitty-Anderson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Annick+Gui%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Annick Gui&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Eulalie+Kanga&#034; class=&#034;hal-auteur&#034;&gt;Eulalie Kanga&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;Note de politique PAC-CI #3, Programme PAC-CI. 2022&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-report&#034;&gt;Rapport&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-03882265v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;ird-03882265&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;figure class='spip_document_457 spip_documents media_pdfjs media_application media_application_pdf'&gt; &lt;!--[if !IE]&gt;&lt;!--&gt;&lt;iframe src=&#034;spip.php?page=pdfjs&amp;id_document=457&#034; width=&#034;100%&#034; height=&#034;600&#034; style=&#034;border: none;&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;!--&lt;![endif]--&gt; &lt;!--[if IE]&gt;&lt;iframe src=&#034;IMG/pdf/prep-ci_note_de_politique_prep_et_offre_sante_globale.pdf&#034; width=&#034;100%&#034; height=&#034;600&#034; style=&#034;border: none;&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;![endif]--&gt; &lt;/figure&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Sexual health needs of female sex workers in C&#244;te d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention</title>
		<link>https://joseph.larmarange.net/Sexual-health-needs-of-female-sex-269</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Sexual-health-needs-of-female-sex-269</guid>
		<dc:date>2020-01-09T12:21:05Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Contraception</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Jean-Marie Masumbuko, Camille Anoma, Soh Kouame, Christine Danel, Serge Paul Eholie, Joseph Larmarange for the ANRS 12361 PrEP-CI Study group &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Objective To describe sexual and reproductive health (SRH) needs of female sex workers (FSWs) to inform the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention in this population. &lt;br class='autobr' /&gt;
Design and setting The ANRS 12361 PrEP-CI cross-sectional and&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Contraception-+" rel="tag"&gt;Contraception&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH85/arton269-92021.jpg?1715149525' class='spip_logo spip_logo_right' width='150' height='85' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Jean-Marie Masumbuko, Camille Anoma, Soh Kouame, Christine Danel, Serge Paul Eholie, Joseph Larmarange for the ANRS 12361 PrEP-CI Study group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Objective&lt;/strong&gt; To describe sexual and reproductive health (SRH) needs of female sex workers (FSWs) to inform the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention in this population.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Design and setting&lt;/strong&gt; The ANRS 12361 PrEP-CI cross-sectional and mixed-methods study was designed and implemented with two community-based organisations in C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Participants&lt;/strong&gt; A convenience sample of 1000 FSWs aged &#8805;18, not known as HIV-positive, completed a standardised questionnaire assessing sociodemographic characteristics, sexual practices, use of community health services and a priori acceptability of PrEP. Twenty-two indepth interviews and eight focus group discussions were also conducted to document FSWs' risky practices and sexual behaviours, experiences with violence and discrimination, attitudes regarding HIV and sexually transmitted infections (STIs), and barriers to SRH services.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt; Although 87% described consistent condom use with clients, more than 22% declared accepting condomless sexual intercourse for a large sum of money. Furthermore, condom use with their steady partner and knowledge of their partner's HIV status were low despite their acknowledged concurrent sexual partnerships. While inconsistent condom use exposed FSWs to STIs and undesired pregnancies, the prevalence of contraceptive strategies other than condoms was low (39%) due to fear of contraception causing sterility. FSWs faced obstacles to accessing SRH care and preferred advice from their peers or self-medication.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt; Despite adoption of preventive behaviour in most cases, FSWs are still highly exposed to HIV. Furthermore, FSWs seem to face several barriers to accessing SRH. Implementing PrEP among FSWs in West Africa, such as in C&#244;te d'Ivoire, constitutes an opportunity to consider the regular follow-up of HIV-negative FSWs. PrEP initiation should not condition access to SRH services; conversely, SRH services could be a way to attract FSWs into HIV prevention. Our results highlight the importance of developing a people-focused approach that integrates all SRH needs when transitioning from PrEP efficacy trials to implementation.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;R9282HML&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Becquet&lt;/span&gt; Valentine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Nouaman&lt;/span&gt; Marcellin, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Masumbuko&lt;/span&gt; Jean-Marie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Anoma&lt;/span&gt; Camille, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Kouame&lt;/span&gt; Soh, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Danel&lt;/span&gt; Christine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Eholie&lt;/span&gt; Serge Paul, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph and &lt;span style=&#034;font-variant: small-caps;&#034;&gt;ANRS 12361 PrEP-CI Study group&lt;/span&gt; (2020) &#8220;Sexual health needs of female sex workers in C&#244;te d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention&#8221;, &lt;span style=&#034;font-style: italic;&#034; &gt;BMJ Open&lt;/span&gt;, 10 (1) (January 1). DOI&#160;: 10.1136/bmjopen-2018-028508. https://bmjopen.bmj.com/content/10/1/e028508.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>La Sant&#233; des travailleuses du sexe en Afrique subsaharienne&#160;: une population toujours expos&#233;e au VIH et soumise &#224; de multiples vuln&#233;rabilit&#233;s</title>
		<link>https://joseph.larmarange.net/La-Sante-des-travailleuses-du-sexe</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/La-Sante-des-travailleuses-du-sexe</guid>
		<dc:date>2019-08-30T07:00:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Communication orale pr&#233;sent&#233;e le 30&#160;ao&#251;t 2019 &#224; Anger dans le cadre du 2&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; congr&#232;s international de l'Institut du Genre sur le th&#232;me Genre et &#201;mancipation. &lt;br class='autobr' /&gt; Auteurs &lt;br class='autobr' /&gt;
Valentine Becquet &amp; Joseph Larmarange &lt;br class='autobr' /&gt;
R&#233;sum&#233; &lt;br class='autobr' /&gt;
Les travailleuses du sexe (TS) constituent une des populations prioritaires des programmes de lutte contre le VIH. Pendant longtemps, le focus a &#233;t&#233; la promotion du pr&#233;servatif et, dans les ann&#233;es 2000, le d&#233;pistage et le traitement des TS infect&#233;es. Ces politiques ont-elles&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH94/arton259-0f22c.jpg?1715140045' class='spip_logo spip_logo_right' width='150' height='94' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Communication orale pr&#233;sent&#233;e le 30&#160;ao&#251;t 2019 &#224; Anger dans le cadre du &lt;a href=&#034;https://congresgenre19.sciencesconf.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;2&lt;sup&gt;e&lt;/sup&gt; congr&#232;s international de l'Institut du Genre&lt;/a&gt; sur le th&#232;me &lt;i&gt;Genre et &#201;mancipation&lt;/i&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Auteurs&lt;/h2&gt;
&lt;p&gt;Valentine Becquet &amp; Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;Les travailleuses du sexe (TS) constituent une des populations prioritaires des programmes de lutte contre le VIH. Pendant longtemps, le focus a &#233;t&#233; la promotion du pr&#233;servatif et, dans les ann&#233;es 2000, le d&#233;pistage et le traitement des TS infect&#233;es. Ces politiques ont-elles v&#233;ritablement enray&#233; la vuln&#233;rabilit&#233; de ces femmes&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? Cette communication pr&#233;sentera des r&#233;sultats issus d'entretiens men&#233;s en 2016 (projet ANRS 12361 PrEP-CI) sur diff&#233;rents sites prostitutionnels d'Abidjan et de San Pedro. Les TS sont en r&#233;alit&#233; expos&#233;es au VIH dans de nombreuses situations, notamment avec leurs partenaires r&#233;guliers, avec des clients les agressant ou payant davantage d'argent pour un rapport non prot&#233;g&#233;. Leur faible pouvoir de n&#233;gociation s'inscrit dans un contexte de domination masculine. &#192; ces vuln&#233;rabilit&#233;s de genre s'ajoutent les vuln&#233;rabilit&#233;s mat&#233;rielles li&#233;es &#224; leurs conditions de travail. Leur mobilit&#233; importante pour contourner leur marginalisation sociale est &#233;galement un facteur de fragilisation. Les nouveaux outils de pr&#233;vention tels que la prophylaxie pr&#233;exposition pourraient selon certains compenser ces vuln&#233;rabilit&#233;s et contribuer &#224; leur &#233;mancipation en termes de sant&#233;. Si cet outil pourrait &#234;tre appropri&#233;, il convient cependant de ne pas consid&#233;rer ces femmes uniquement au prisme du VIH, puisqu'elles ont de nombreux autres besoins en sant&#233; sexuelle et reproductive et font face plus globalement &#224; un probl&#232;me d'acc&#232;s aux droits humains fondamentaux.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;f&#233;rence&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;YZZXQW8W&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Becquet&lt;/span&gt; Valentine and &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2019) &#8220;La Sant&#233; des travailleuses du sexe en Afrique subsaharienne : une population toujours expos&#233;e au VIH et soumise &#224; de multiples vuln&#233;rabilit&#233;s&#8221; (communication orale), presented at the &lt;span style=&#034;font-style: italic;&#034; &gt;2e congr&#232;s international de l'Institut du Genre&lt;/span&gt;, Anger. https://congresgenre19.sciencesconf.org/.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Sexual health needs of female sex workers reached by two NGOs in C&#244;te d'Ivoire: considerations for the future implementation of PrEP</title>
		<link>https://joseph.larmarange.net/Sexual-health-needs-of-female-sex</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Sexual-health-needs-of-female-sex</guid>
		<dc:date>2019-07-31T12:18:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Organisation des soins</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Oral communication presented at AIDS Impact 2019, July 31, 2019, in London. &lt;br class='autobr' /&gt; Authors &lt;br class='autobr' /&gt;
Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Jean-Marie Masumbuko, Camille Anoma, Soh Kouam&#233;, Christine Danel, Serge Eholi&#233;, Joseph Larmarange &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Aim &lt;br class='autobr' /&gt;
In West Africa, most countries have mixed HIV epidemics; new tools such as pre-exposure prophylaxis (PrEP) should target in priority most affected populations, particularly female sex workers (FSWs). This paper describes sexual and&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Organisation-des-soins-+" rel="tag"&gt;Organisation des soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH84/arton257-58ed0.jpg?1715149525' class='spip_logo spip_logo_right' width='150' height='84' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Oral communication presented at &lt;a href=&#034;http://www.aidsimpact.com/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;AIDS Impact 2019&lt;/a&gt;, July 31, 2019, in London.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Jean-Marie Masumbuko, Camille Anoma, Soh Kouam&#233;, Christine Danel, Serge Eholi&#233;, Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Aim&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;In West Africa, most countries have mixed HIV epidemics; new tools such as pre-exposure prophylaxis (PrEP) should target in priority most affected populations, particularly female sex workers (FSWs). This paper describes sexual and reproductive health (SRH) needs of FSWs in C&#244;te d'Ivoire to inform the future implementation of PrEP in this population.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Method/Issue&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The ANRS 12361 PrEP-CI cross-sectional and mixed-methods study was designed and implemented with two Ivorian community-based organizations. 1000 FSWs completed a standardized questionnaire assessing women's sociodemographic characteristics, sexual practices and behaviors, use of community health services, a priori acceptability of PrEP. Twenty-two in-depth interviews and eight focus group discussions were conducted at prostitution sites. FSWs were interviewed about risky practices and sexual behaviors, experiences with violence and discrimination, attitudes regarding HIV and sexually transmitted infections (STIs), and barriers to SRH services.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results/Comments&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The quantitative and qualitative results showed that FSWs were highly exposed to HIV despite their use of condoms with clients. 91% did not use condoms with their regular partner, despite their acknowledged concurrent sexual partnerships. 23% accepted condomless sexual intercourse for a large sum of money, especially when they had had few previous clients. Moreover, FSWs faced many unmet needs regarding SRH beyond HIV prevention and treatment. Inconsistent condom use exposed FSWs to STIs and undesired pregnancies. However, the prevalence of contraceptive use was low (40%) due to fear of contraception causing sterility. FSWs faced obstacles in accessing SRH care and preferred advice from their peers or self-medication.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Discussion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Implementing PrEP among FSWs in West Africa, such as in C&#244;te d'Ivoire, constitutes an opportunity to consider the chronic follow-up of HIV-negative FSWs. PrEP initiation should not condition access to SRH services; conversely, SRH services could be a way to attract FSWs into practicing HIV prevention. Our results highlight the importance of developing a people-focused approach that integrates all SRH needs when transitioning from PrEP efficacy trials to implementation.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;3QLN987L&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Becquet&lt;/span&gt; Valentine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Nouaman&lt;/span&gt; Marcellin, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Masumbuko&lt;/span&gt; Jean-Marie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Anoma&lt;/span&gt; Camille, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Kouam&#233;&lt;/span&gt; Soh, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Danel&lt;/span&gt; Christine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Eholi&#233;&lt;/span&gt; Serge and &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2019) &#8220;Sexual health needs of female sex workers reached by two NGOs in C&#244;te d'Ivoire: considerations for the future implementation of PrEP&#8221; (communication orale), presented at the &lt;span style=&#034;font-style: italic;&#034; &gt;AIDS Impact&lt;/span&gt;, London. http://www.aidsimpact.com/abstracts/-LZFgxedD3IcXCPGWlOB.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Female sex workers and HIV acquisition in C&#244;te d'Ivoire: the burden of precariousness and working conditions (ANRS 12361 PREP-CI)</title>
		<link>https://joseph.larmarange.net/Female-sex-workers-and-HIV</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Female-sex-workers-and-HIV</guid>
		<dc:date>2019-05-17T05:00:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Pauvret&#233;</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>&#201;pid&#233;miologie</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>

		<description>
&lt;p&gt;Oral presentation of a poster at the 2019 INTEREST Workshop, the 17&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; of May, 2019, Accra, Ghana. &lt;br class='autobr' /&gt; Authors &lt;br class='autobr' /&gt;
N'zebo Marcellin Nouaman, Valentine Becquet, Jean-Marie Masumbuko, Camille Anoma, Kouam&#233; Soh, M&#233;lanie Plazy, Christine Danel, Serge Eholi&#233; and Joseph Larmarange &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background Female sex workers (FSW) are a population at high risk of HIV acquisition. New tools to diagnose recent HIV infection may be used to better describe risk of HIV acquisition in this group. The ANRS&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Pauvrete-+" rel="tag"&gt;Pauvret&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Epidemiologie-+" rel="tag"&gt;&#201;pid&#233;miologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH102/arton248-05adc.jpg?1715130051' class='spip_logo spip_logo_right' width='150' height='102' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Oral presentation of a poster at the &lt;a href=&#034;http://interestworkshop.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;2019 INTEREST Workshop&lt;/a&gt;, the 17&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; of May, 2019, Accra, Ghana.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;N'zebo Marcellin Nouaman, Valentine Becquet, Jean-Marie Masumbuko, Camille Anoma, Kouam&#233; Soh, M&#233;lanie Plazy, Christine Danel, Serge Eholi&#233; and Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Female sex workers (FSW) are a population at high risk of HIV acquisition. New tools to diagnose recent HIV infection may be used to better describe risk of HIV acquisition in this group. The ANRS 12361 PrEP-CI project aimed to estimate HIV incidence and describe risk factors among FSW in C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The study was conducted between September 2016 and March 2017 among FSW aged &#8805;18 years old in Abidjan and San Pedro. Two rapid tests for recent HIV infection (Determine&#174;, Alere and Vikia&#174;, bio M&#233;rieux) were offered to FSW; in case of positive result, a dried blood sport was collected and window period of infection determined using a test for recent infection (EIA-RI) adapted to the Ivorian context. A standardized sociodemographic questionnaire was then administered to FSW by female peer educators, completed with qualitative interviews and focus groups with 60 FSW.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;1000 SW (400 in San Pedro and 600 in Abidjan) with a median age of 25 years (interquartile range: 21-29) were included in the study and screened for HIV. Of these, 39 were diagnosed with HIV, 7 of which were newly infected (mean duration of infection was 113 days), corresponding to an HIV incidence of 2.3% [95% confidence interval: 1.6 - 3.1%]. The incidence was higher in San Pedro (3.3% [2.2-4.5]) than in Abidjan (1.6% [1.1-2.2]); this can be explained by qualitative data in which FSW in San Pedro expressed difficulties (distance, time, costs ...) in accessing health care services and prevention methods, particularly regarding condoms. HIV infection was also associated with vulnerability: the incidence was higher among those who charged &#8804; 2000 CFA francs per intercourse (3.3% vs. 0.7%), those who performed on the streets or in hotels (5.4% and 4.2%, respectively, vs. 3.9% in brothel and 0.8% in bar &#8211; drinking spot), and among those who had more than 5 clients the last working day (6.1% vs. 1.8% among those who had under 5 clients) and who could be more difficult to identify and refer to HIV prevention services by female peer educators. Finally, FSW under &lt;25 years old were at higher risk of infection (2.8%) than older ones (1.8%), and HIV incidence was associated with other sexually transmitted infections (STI) (2.5% in those who had &#8805; 1 STI in the last 12 months vs. 1.9%). Contrary to expectations, an extensive sex work experience did not reduce exposure to HIV, when we compared FSW who had been working for more than 3 years with the ones who had newly arrived in the sex work industry (2.5% vs. 2.0%).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;This study is one of the first to estimate HIV incidence in C&#244;te d'Ivoire among FSW. This key population is much more exposed than the rest of the general population (2.3% vs. 0.06% estimated by UNAIDS). New infections seem to concentrated among younger FSW in precarious situations and working in remote areas, such as San Pedro area. These vulnerable subgroups should therefore be a priority target for prevention programs such as pre-exposure prophylaxis (PrEP) as recommended by WHO.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;JL27FEV8&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Nouaman&lt;/span&gt; Marcellin, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Becquet&lt;/span&gt; Valentine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Masumbuko&lt;/span&gt; Jean-Marie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Anoma&lt;/span&gt; Camille, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Soh&lt;/span&gt; Kouam&#233;, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Danel&lt;/span&gt; Christine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Eholi&#233;&lt;/span&gt; Serge and &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2019) &#8220;Female sex workers and HIV acquisition in C&#244;te d'Ivoire: the burden of precariousness and working conditions (ANRS 12361 PREP-CI)&#8221; (poster discussion), presented at the &lt;span style=&#034;font-style: italic;&#034; &gt;INTEREST Workshop&lt;/span&gt;, Accra.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>&#201;valuation de l'incidence du VIH chez des travailleuses du sexe en C&#244;te d'Ivoire (PREPCI ANRS 12361)</title>
		<link>https://joseph.larmarange.net/Evaluation-de-l-incidence-du-VIH</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Evaluation-de-l-incidence-du-VIH</guid>
		<dc:date>2018-04-08T15:45:01Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>&#201;pid&#233;miologie</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>

		<description>
&lt;p&gt;Communication orale pr&#233;sent&#233;e le 5&#160;avril 2018 lors de la 9&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence francophone sur le VIH et les h&#233;patites virales &#224; Bordeaux. &lt;br class='autobr' /&gt; Auteurs &lt;br class='autobr' /&gt;
N'zebo Marcellin Nouaman, Valentine Becquet, Jean-Marie Masumbuko, Camille Anoma, Kouam&#233; Soh, M&#233;lanie Plazy, Christine Danel, Serge Eholi&#233;, Joseph Larmarange &lt;br class='autobr' /&gt;
Vid&#233;o&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Epidemiologie-+" rel="tag"&gt;&#201;pid&#233;miologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH75/arton226-08fd5.jpg?1715174700' class='spip_logo spip_logo_right' width='150' height='75' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Communication orale pr&#233;sent&#233;e le 5&#160;avril 2018 lors de la &lt;a href=&#034;http://www.afravih2018.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;9&lt;sup&gt;e&lt;/sup&gt; conf&#233;rence francophone sur le VIH et les h&#233;patites virales&lt;/a&gt; &#224; Bordeaux.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Auteurs&lt;/h2&gt;
&lt;p&gt;N'zebo Marcellin Nouaman, Valentine Becquet, Jean-Marie Masumbuko, Camille Anoma, Kouam&#233; Soh, M&#233;lanie Plazy, Christine Danel, Serge Eholi&#233;, Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Vid&#233;o&lt;/h2&gt;&lt;div class=&#034;spip_document_ spip_document spip_documents spip_document_video ressource oembed oembed_video oembed_video oembed_youtube&#034; &gt; &lt;figure class=&#034;spip_doc_inner&#034;&gt; &lt;div class=&#034;oembed oe-video async clearfix&#034; style=&#034;max-width:800px;&#034;&gt; &lt;div class=&#034;rwd-video-container oe-play-button&#034; style=&#034;width:100%;height:0;padding-bottom:56.25%;background-image:url('https://i.ytimg.com/vi/P4_Albn2IRI/hqdefault.jpg');background-repeat:no-repeat;background-position:center;background-size:cover;&#034; data-content=&#034;%3Ciframe%20width%3D%22800%22%20height%3D%22450%22%20src%3D%22https%3A%2F%2Fwww.youtube-nocookie.com%2Fembed%2FP4_Albn2IRI%3Ffeature%3Doembed%26autoplay%3D1%22%20frameborder%3D%220%22%20allow%3D%22accelerometer%3B%20autoplay%3B%20clipboard-write%3B%20encrypted-media%3B%20gyroscope%3B%20picture-in-picture%3B%20web-share%22%20referrerpolicy%3D%22strict-origin-when-cross-origin%22%20allowfullscreen%20title%3D%22S6%20-%20Populations%20cl%C3%A9s%20-%20%C3%89valuation%20de%20l%E2%80%99incidence%20du%20VIH%20chez%20des%20travailleuses%20du%20sexe...%22%3E%3C%2Fiframe%3E&#034;&gt; &lt;button&gt;&lt;span class=&#034;oe-play-button_label&#034;&gt;Lecture&lt;/span&gt;&lt;/button&gt; &lt;/div&gt; &lt;style&gt;&lt;!--/**/.oe-video .loading {background-image:url(&#034;prive/themes/spip/images/searching.gif&#034;)!important;background-size:auto !important;}/**/--&gt;&lt;/style&gt;
&lt;/div&gt; &lt;figcaption class=&#034;spip_doc_legende&#034;&gt;
&lt;div class=&#034;spip_doc_titre&#034; style=&#034;max-width:800px;&#034;&gt;&lt;a href=&#034;https://www.youtube.com/watch?v=P4_Albn2IRI&#034; class=&#034;oe-title&#034;&gt;S6 - Populations cl&#233;s - &#201;valuation de l'incidence du VIH chez des travailleuses du sexe...&lt;/a&gt; &lt;span class=&#034;oe-author&#034;&gt;&lt;br/&gt;&lt;span class=&#034;oe-author_par&#034;&gt;par &lt;/span&gt;&lt;a href=&#034;https://www.youtube.com/@AFRAVIH&#034; class=&#034;oe-author_name&#034;&gt;AFRAVIH 2018&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&#034;spip_doc_titre oembed-source&#034;&gt;&lt;a href=&#034;https://www.youtube.com/watch?v=P4_Albn2IRI&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://www.youtube.com/watch?v=P4_Albn2IRI&lt;/a&gt;&lt;/div&gt;
&lt;/figcaption&gt; &lt;div class=&#034;base64javascript176631527269d75103d517f2.47566889&#034; title=&#034;PHNjcmlwdD5qUXVlcnkoZnVuY3Rpb24oKXsgalF1ZXJ5KCcub2VtYmVkLm9lLXZpZGVvLmFzeW5jJykubm90KCcuZG9uZScpLmFkZENsYXNzKCdkb25lJykub24oJ2NsaWNrJywgJy5vZS1wbGF5LWJ1dHRvbicsZnVuY3Rpb24oZSl7dmFyICRtZSA9IGpRdWVyeSh0aGlzKSxjb250ZW50ID0gZGVjb2RlVVJJQ29tcG9uZW50KCRtZS5kYXRhKCdjb250ZW50JykpOyRtZS5yZW1vdmVDbGFzcygnb2UtcGxheS1idXR0b24nKS5hZGRDbGFzcygnbG9hZGluZycpLmh0bWwoY29udGVudCk7fSl9KTwvc2NyaXB0Pg==&#034;&gt;&lt;/div&gt; &lt;/figure&gt;
&lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Contexte&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Bien que les travailleuses du sexe (TS) constituent une population particuli&#232;rement &#224; risque du VIH, la compr&#233;hension du fardeau du VIH reste limit&#233;e dans cette population en Afrique subsaharienne. Le projet PrEP-CI ANRS 12361 comportait une estimation de l'incidence de l'infection VIH chez des TS en C&#244;te d'Ivoire &#224; l'aide de tests d'infection r&#233;cente.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;M&#233;thodes&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;L'&#233;tude a &#233;t&#233; conduite entre septembre 2016 et mars 2017 aupr&#232;s de TS &#226;g&#233;es de 18 ans et plus &#224; Abidjan et &#224; San Pedro, en mobilisant une m&#233;thodologie mixte&#160;:(i) des entretiens qualitatifs individuels et des focus groupes aupr&#232;s de 60 TS,(ii) un questionnaire sociod&#233;mographique standardis&#233; ainsi qu'un d&#233;pistage du VIH par deux tests rapides (Determine&#174;, Alere et Vikia&#174;, bio M&#233;rieux) administr&#233;s par des paires &#233;ducatrices sur les sites prostitutionnels aupr&#232;s de 1000 TS. En cas de positivit&#233;, un pr&#233;l&#232;vement sur DBS a &#233;t&#233; r&#233;alis&#233; pour d&#233;terminer la fen&#234;tre d'infection &#224; l'aide d'un test d'infection r&#233;cente (EIA-RI) adapt&#233; au contexte ivoirien.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;R&#233;sultats&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;1000 TS (400 &#224; San Pedro, 600 &#224; Abidjan) avec un &#226;ge m&#233;dian de 25 ans [Intervalle Interquartile = 21-29] ont &#233;t&#233; incluses dans l'&#233;tude et ont &#233;t&#233; d&#233;pist&#233;es pour le VIH. Parmi elles, 39 ont &#233;t&#233; diagnostiqu&#233;es VIH+, dont 7 infect&#233;es r&#233;cemment (dur&#233;e moyenne de la dur&#233;e d'infection de 113 jours), correspondant &#224; une incidence du VIH de 2,2%.&lt;/p&gt;
&lt;p&gt;L'incidence est plus &#233;lev&#233;e &#224; San Pedro (3,2%) qu'&#224; Abidjan (1,5%). Ces r&#233;sultats sont &#224; mettre en regard des donn&#233;es qualitatives&#160;: les TS de San Pedro ont t&#233;moign&#233; de difficult&#233;s (distance, horaires, co&#251;ts &#8230;) &#224; acc&#233;der aux soins de sant&#233; et aux moyens de pr&#233;vention, notamment le pr&#233;servatif. L'infection &#224; VIH est &#233;galement associ&#233;e &#224; la vuln&#233;rabilit&#233;&#160;: l'incidence est plus &#233;lev&#233;e chez celles qui pratiquent des passes &#8804; 2000 CFA (3,1% vs. 0,7%)&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; chez celles qui exercent sur les trottoirs (5,1%) et dans les h&#244;tels (3,8%)&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; et chez celles qui ne travaillent qu'une fois par semaine (2,9% vs. 0 cas incident observ&#233; chez celles qui travaillent tous les jours). Les TS travaillant occasionnellement sont plus difficilement identifi&#233;es par les paires &#233;ducatrices et ont moins acc&#232;s &#224; la pr&#233;vention. Enfin, les TS de moins de 25 ans sont plus &#224; risque d'infection (2,6%) que celles de plus &#226;g&#233;es (1,6%) et l'incidence du VIH est associ&#233;e aux autres IST (2,3% chez celles ayant eu &#8805;1 IST au cours des 12 derniers mois vs 1,8%).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Cette &#233;tude est l'une des premi&#232;res &#224; estimer l'incidence du VIH en C&#244;te d'Ivoire chez les TS. Cette population est beaucoup plus expos&#233;e que le reste de la population g&#233;n&#233;rale (2,2% vs. 0,06% estim&#233; par l'Onusida). Les nouvelles infections se concentrent chez les TS plus jeunes, en situation pr&#233;caire et travaillant dans des zones recul&#233;es, en particulier dans la r&#233;gion de San Pedro. Ces sous-groupes vuln&#233;rables doivent donc &#234;tre vis&#233;s en priorit&#233; par les programmes de pr&#233;vention et devraient se voir proposer une prophylaxie pr&#233;exposition (PrEP) selon les recommandations de l'OMS.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;f&#233;rence&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;EE8UFFWB&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Nouaman&lt;/span&gt; Marcellin, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Becquet&lt;/span&gt; Valentine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Masumbuko&lt;/span&gt; Jean-Marie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Anoma&lt;/span&gt; Camille, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Soh&lt;/span&gt; Kouam&#233;, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Danel&lt;/span&gt; Christine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Eholi&#233;&lt;/span&gt; Serge and &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2018) &#8220;&#201;valuation de l'incidence du VIH chez des travailleuses du sexe en C&#244;te d'Ivoire (PREPCI ANRS 12361)&#8221; (communication orale S6.04), presented at the &lt;span style=&#034;font-style: italic;&#034; &gt;9e Conf&#233;rence Internationale Francophone sur le VIH et les H&#233;patites Virales (AFRAVIH 2018)&lt;/span&gt;, Bordeaux.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Implementing preexposure prophylaxis among key populations: an opportunity for patient-centered services and management of hepatitis B</title>
		<link>https://joseph.larmarange.net/Implementing-preexposure</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Implementing-preexposure</guid>
		<dc:date>2018-03-19T13:41:53Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Larmarange, Joseph; Becquet, Valentine; Masumbuko, Jean-Marie; Nouaman, Marcellin; Plazy, M&#233;lanie; Danel, Christine; Eholi&#233;, Serge &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
When taken properly, Tenofovir-based oral preexposure prophylaxis (PrEP) has been proven to be efficient to prevent HIV acquisition. Since 2015, PrEP is recommended by the WHO for populations at &#8216;substantial risk' of HIV. However, WHO points out the need for additional research on PrEP in &#8216;real life' on questions such as demand creation for&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH113/arton224-b349a.jpg?1715646678' class='spip_logo spip_logo_right' width='150' height='113' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Larmarange, Joseph; Becquet, Valentine; Masumbuko, Jean-Marie; Nouaman, Marcellin; Plazy, M&#233;lanie; Danel, Christine; Eholi&#233;, Serge&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;When taken properly, Tenofovir-based oral preexposure prophylaxis (PrEP) has been proven to be efficient to prevent HIV acquisition. Since 2015, PrEP is recommended by the WHO for populations at &#8216;substantial risk' of HIV. However, WHO points out the need for additional research on PrEP in &#8216;real life' on questions such as demand creation for oral PrEP; best delivery models in different contexts and for different populations; social and behavioral impact of PrEP; or integration of PrEP services with other services. Transitioning from efficacy trials to implementation requires to adapt interventions. Preliminary research (ANRS 12361 PrEP-CI) has been conducted in C&#244;te d'Ivoire (CI) in collaboration with community non-governmental organizations to explore relevance and feasibility of implementing a PrEP program among female sex workers, one of the most exposed populations countrywide (estimated HIV prevalence: 29%). The following observations emerged from that collective work.&lt;/p&gt;
&lt;p&gt;All efficacy PrEP trials provided a range of sexual healthcare services in addition to PrEP drugs. Such services appeared essential for any PrEP program. By design, they were conditional to PrEP use. However, regardless of their interest in using PrEP, female sex workers interviewed in C&#244;te d'Ivoire, and more broadly key populations worldwide, have many unmet sexual and reproductive health needs: sexually transmitted infections screening and care, contraception and birth control, menstrual management, addictions and risky behaviors&#8230; When transitioning to real life, we should not reproduce the service model of efficacy PrEP trials, that is a PrEP program with additional services. Instead, a paradigm shift toward a patient-centered approach should be preferred, that is offering sexual and reproductive health services in which PrEP is an option but not mandatory.&lt;/p&gt;
&lt;p&gt;In Western and Central Africa, the prevalence of hepatitis B is relatively high. In Cote d'Ivoire, more than 11% of new blood donors were positive for hepatitis B surface antigen in 2008&#8211;2012. Tenofovir is also used for hepatitis B treatment. But, currently, treatment is not free for monoinfected hepatitis B patients, whereas it is covered by AIDS programs for HIV-hepatitis B coinfected patients. In such context, it would be ethically unacceptable to provide free HIV PrEP without taking into account patients in needs of hepatitis B treatment. Actually, for those patients, offering Tenofovir-based HIV PrEP constitutes an opportunity to simultaneously treat their hepatitis B. It requires to integrate WHO recommendations on hepatitis B within PrEP guidelines, possibly to simplify hepatitis B care algorithms and to allow hepatitis B care in decentralized sexual health clinics and not only in hospital services. Most efficacy PrEP trials excluded hepatitis B patients. Additional clinical research exploring interactions between HIV PrEP and hepatitis B treatment, in particular the risk of flare if PrEP is stopped, is required.&lt;/p&gt;
&lt;p&gt;PrEP programs could be built on the existing community services for HIV care and treatment. Providing services for HIV positives and HIV negatives within the same clinics could be a way of minimizing the stigma associated with entry and retention into HIV care. In addition, HIV patients have unmet sexual and reproductive health needs as well. Integrating services together and transforming HIV clinics into sexual health clinics could lead to many health outcomes improvements and also to possible cost sharing and savings.&lt;/p&gt;
&lt;p&gt;So far, the focus of HIV programs has mainly been on reaching individuals never tested for HIV, identifying new positives and linking them to HIV care and treatment. Transitioning PrEP from trials to implementation constitutes an opportunity for developing people-centered approaches integrating all sexual and reproductive health services together, including hepatitis B. It is crucial to avoid a silo-based perspective in which services are separated from each other. Moving from HIV care clinics to sexual health clinics would allow to globally improve the health of key populations and their partners, beyond HIV outcomes alone. To ensure the success of new prevention programs, we have to take the next step forward. Beyond biomedical innovations, innovations in terms of intervention implementation, delivery models and public health policies are urgently required, in particular in Western and Central Africa. Scaling-up PrEP is a key moment. We should not miss out on this opportunity.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;KVK3AIDF&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Becquet&lt;/span&gt; Valentine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Masumbuko&lt;/span&gt; Jean-Marie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Nouaman&lt;/span&gt; Marcellin, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Danel&lt;/span&gt; Christine and &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Eholi&#233;&lt;/span&gt; Serge (2018) &#8220;Implementing preexposure prophylaxis among key populations: an opportunity for patient-centered services and management of hepatitis B&#8221;, &lt;span style=&#034;font-style: italic;&#034; &gt;AIDS&lt;/span&gt;, 32 (6) (March 27), p.&#160;829. DOI&#160;: 10.1097/qad.0000000000001749. https://journals.lww.com/aidsonline/Fulltext/2018/03270/Implementing_preexposure_prophylaxis_among_key.17.aspx.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>The challenges of implementing PrEP: the case of female sex workers in C&#244;te d'Ivoire</title>
		<link>https://joseph.larmarange.net/The-challenges-of-implementing</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/The-challenges-of-implementing</guid>
		<dc:date>2018-01-07T18:36:19Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>

		<description>
&lt;p&gt;Poster presented at 19&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; ICASA International Conference on AIDS and STIs in Africa in Abidjan the 6&#160;December 2017. &lt;br class='autobr' /&gt; Authors &lt;br class='autobr' /&gt;
Becquet Valentine, Nouaman Marcellin, Masumbuko Jean-Marie, Anoma Camille, Soh Kouam&#233;, Alain Tristan, Plazy M&#233;lanie, Danel Christine, Eholi&#233; Serge et Larmarange Joseph &lt;br class='autobr' /&gt; R&#233;sum&#233; &lt;br class='autobr' /&gt;
Contexte Depuis 2015, la prophylaxie pr&#233;exposition (PrEP) du VIH est recommand&#233;e par l'OMS pour les populations dites &#171; &#224; risque substantiel &#187; telles que les travailleuses du sexe (TS).&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH113/arton217-2c928.jpg?1715174700' class='spip_logo spip_logo_right' width='150' height='113' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Poster presented at &lt;a href=&#034;http://icasa2017cotedivoire.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;19&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; ICASA International Conference on AIDS and STIs in Africa&lt;/a&gt; in Abidjan the 6&#160;December 2017.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Becquet Valentine, Nouaman Marcellin, Masumbuko Jean-Marie, Anoma Camille, Soh Kouam&#233;, Alain Tristan, Plazy M&#233;lanie, Danel Christine, Eholi&#233; Serge et Larmarange Joseph&lt;/p&gt;
&lt;div lang='fr'&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Contexte&lt;/strong&gt; Depuis 2015, la prophylaxie pr&#233;exposition (PrEP) du VIH est recommand&#233;e par l'OMS pour les populations dites &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#224; risque substantiel&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187; telles que les travailleuses du sexe (TS). Cependant, il y a peu de donn&#233;es sur les modalit&#233;s pratiques d'int&#233;gration de la PrEP dans les activit&#233;s destin&#233;es &#224; ces populations.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Objectif&lt;/strong&gt; Identifier les enjeux, leviers et obstacles potentiels &#224; la mise en &#339;uvre d'un programme PrEP aupr&#232;s des TS en C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;M&#233;thodes&lt;/strong&gt; Le projet PrEP-CI ANRS 12361, men&#233; entre septembre 2016 et mars 2017 en collaboration avec deux ONG communautaires (Espace Confiance et Aprosam) comportait (i) un questionnaire standardis&#233; administr&#233; par des paires &#233;ducatrices sur sites prostitutionnels, (ii) des entretiens individuels et des focus groupes men&#233;s aupr&#232;s de 60 TS et (iii) des ateliers de travail avec des ONG communautaires.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;R&#233;sultats&lt;/strong&gt; Au total 400 TS &#224; San Pedro et 600 &#224; Abidjan, d'un &#226;ge m&#233;dian de 25 ans [Intervalle Inter-Quartile (IIQ)&#160;: 21-29], ont &#233;t&#233; enqu&#234;t&#233;es. 86,9&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% d&#233;claraient utiliser r&#233;guli&#232;rement le pr&#233;servatif. Cependant, 58,7&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% avaient eu au moins un rapport sans pr&#233;servatif au cours des 7 derniers jours, 22,6&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% accepteraient des rapports sans pr&#233;servatif contre une forte somme d'argent et 87,4&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% n'utilisent pas de pr&#233;servatif avec leur partenaire r&#233;gulier. Concernant les besoins en sant&#233; sexuelle et reproductive&#160;: 43,0&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% des TS ont d&#233;j&#224; v&#233;cu une grossesse non d&#233;sir&#233;e mais seules 39,1&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% utilisent une contraception&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; 35,9&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% travaillent pendant leurs menstruations et 64,7&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% ont contract&#233; une IST au cours des 12 derniers mois. Seules 67,3% ont consult&#233; un professionnel de sant&#233; au cours des 12 derniers mois. Les entretiens r&#233;v&#232;lent que malgr&#233; le travail des paires &#233;ducatrices sur les sites prostitutionnels, le suivi des TS VIH- dans les structures d&#233;di&#233;es n'est pas optimal. Si elles sont d&#233;pist&#233;es plus ou moins r&#233;guli&#232;rement sur le terrain, elles se rendent rarement dans les cliniques communautaires, &#233;voquant des horaires ou des localisations peu pratiques, ou la crainte d'&#234;tre identifi&#233;e comme TS dans le quartier de la clinique. En cas de rupture de pr&#233;servatif, les TS pr&#233;f&#232;rent se tourner vers l'autom&#233;dication. Les professionnels de terrain soulignent la n&#233;cessit&#233; de ne pas s&#233;parer suivi des VIH+ et des VIH- afin de r&#233;duire les risques de stigmatisation. Par ailleurs, ils soul&#232;vent la probl&#233;matique &#233;thique pos&#233;e par l'h&#233;patite B, infection end&#233;mique non prise en charge financi&#232;rement en C&#244;te d'Ivoire et dont le traitement est compos&#233; des m&#234;mes antir&#233;troviraux que ceux pour la PrEP.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt; La mise en place de la PrEP chez des TS n&#233;cessiterait de d&#233;velopper une offre globale de soins en sant&#233; sexuelle et reproductive incluant un suivi chronique des TS tant VIH+ que VIH-, ainsi que le d&#233;pistage et le traitement de l'h&#233;patite B, tout en articulant cliniques communautaires et strat&#233;gies mobiles sur les sites prostitutionnels. Au-del&#224; de la r&#233;duction de l'exposition au VIH des TS et leurs partenaires, la mise en place d'une telle approche serait une opportunit&#233; pour am&#233;liorer plus globalement l'&#233;tat sanitaire de ces femmes vuln&#233;rables.&lt;/p&gt;
&lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;6FPWBVNU&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Becquet&lt;/span&gt; Valentine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Nouaman&lt;/span&gt; Marcellin, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Masumbuko&lt;/span&gt; Jean-Marie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Anoma&lt;/span&gt; Camille, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Soh&lt;/span&gt; Kouam&#233;, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Alain&lt;/span&gt; Tristan, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Danel&lt;/span&gt; Christine, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Eholi&#233;&lt;/span&gt; Serge and &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2017) &#8220;The challenges of implementing PrEP: the case of female sex workers in C&#244;te d'Ivoire&#8221; (poster n&#176;WEPDC159), presented at the &lt;span style=&#034;font-style: italic;&#034; &gt;19th ICASA International Conference on AIDS and STIs in Africa&lt;/span&gt;, Abidjan.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>



</channel>

</rss>
